Crossject Société Anonyme (EPA:ALCJ)
2.330
-0.020 (-0.85%)
Oct 20, 2025, 1:38 PM CET
Crossject Société Anonyme Revenue
Crossject Société Anonyme had revenue of 1.48 million EUR in the half year ending June 30, 2025, a decrease of -52.13%. This brings the company's revenue in the last twelve months to 4.03 million, up 71.18% year-over-year. In the year 2024, Crossject Société Anonyme had annual revenue of 4.12 million with 6.28% growth.
Revenue (ttm)
4.03M
Revenue Growth
+71.18%
P/S Ratio
30.73
Revenue / Employee
39.54K
Employees
102
Market Cap
123.94M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.12M | 243.00K | 6.28% |
Dec 31, 2023 | 3.87M | -3.19M | -45.18% |
Dec 31, 2022 | 7.06M | 583.00K | 9.00% |
Dec 31, 2021 | 6.48M | 1.64M | 33.77% |
Dec 31, 2020 | 4.84M | -58.27K | -1.19% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 45.74B |
EssilorLuxottica Société anonyme | 27.24B |
Eurofins Scientific SE | 7.14B |
emeis Société anonyme | 5.77B |
Clariane SE | 5.31B |
bioMérieux | 4.12B |
Ipsen | 3.76B |
Sartorius Stedim Biotech | 2.95B |